Inventor · disambiguated record
James Dodge
Also filed as: DODGE JAMES · DODGE JAMES C
11 granted patents·13 pending applications·72 citations·filing 2005–2023
89Inventor score
Top patents by PatentIndex Score
24 records- 0193US9034836B2Gene therapy for amyotrophic lateral sclerosis and other spinal cord disordersDODGE JAMES·Filed 2008·Granted May 19, 2015·27 cites·9 claims
- 0292US11253485B2Slow intraventricular deliveryGENZYME CORP·Filed 2019·Granted Feb 22, 2022·4 cites·15 claims
- 0391US8796236B2Gene therapy for lysosomal storage diseasesDODGE JAMES·Filed 2009·Granted Aug 5, 2014·12 cites·7 claims
- 0490US8926967B2Intraventricular enzyme delivery for lysosomal storage diseasesDODGE JAMES·Filed 2008·Granted Jan 6, 2015·13 cites·29 claims
- 0586US10080783B2Intraventricular enzyme delivery for lysosomal storage diseasesGENZYME CORP·Filed 2014·Granted Sep 25, 2018·6 cites·22 claims
- 0685US10744210B2Gene therapy for spinal cord disordersDODGE JAMES·Filed 2007·Granted Aug 18, 2020·8 cites·10 claims
- 0783US11957765B2Gene therapy for neurometabolic disordersGENZYME CORP·Filed 2020·Granted Apr 16, 2024·1 cites·9 claims
- 0878US2023364200A1Gene therapy for amyotrophic lateral sclerosis and other spinal cord disordersGENZYME CORP·Filed 2022·Application pending·0 cites
- 0977US2023287366A1Gene therapy for niemann-pick disease type aGENZYME CORP·Filed 2023·Application pending·0 cites
- 1075US11554161B2Gene therapy for amyotrophic lateral sclerosis and other spinal cord disordersGENZYME CORP·Filed 2019·Granted Jan 17, 2023·0 cites·4 claims
- 1172US2021228692A1Intraventricular enzyme delivery for lysosomal storage diseasesGENZYME CORP·Filed 2020·Application pending·0 cites
- 1271US2022370348A1Slow intraventricular deliveryGENZYME CORP·Filed 2022·Application pending·0 cites
- 1369US10632213B2Gene therapy for neurometabolic disordersPASSINI MARCO A·Filed 2007·Granted Apr 28, 2020·1 cites·10 claims
- 1464US11369693B2Gene therapy for lysosomal storage diseasesGENZYME CORP·Filed 2014·Granted Jun 28, 2022·0 cites·3 claims
- 1562US2009123451A1Slow intraventricular deliveryGENZYME CORP·Filed 2008·Application pending·0 cites
- 1662US2021008227A1Gene therapy for spinal cord disordersGENZYME CORP·Filed 2020·Application pending·0 cites
- 1760US2009117156A1Gene therapy for niemann-pick disease type aGENZYME CORP·Filed 2008·Application pending·0 cites
- 1860US2019083582A1Intraventricular enzyme delivery for lysosomal storage diseasesGENZYME CORP·Filed 2018·Application pending·0 cites
- 1958US2020080066A1Gene therapy for niemann-pick disease type aGENZYME CORP·Filed 2019·Application pending·0 cites
- 2057US10913956B2Gene therapy for neurometabolic disordersGENZYME CORP·Filed 2016·Granted Feb 9, 2021·0 cites·4 claims
- 2150US2016067312A1Gene therapy for amyotrophic lateral sclerosis and other spinal cord disordersGENZYME CORP·Filed 2015·Application pending·0 cites
- 2249US2009105141A1Intraventricular protein delivery for amyotrophic lateral sclerosisGENZYME CORP·Filed 2008·Application pending·0 cites
- 2345US2016287549A1Novel methods for treating neurodegenerative diseasesGENZYME CORP·Filed 2014·Application pending·0 cites
- 2435US2006171926A1Gene therapy for neurometabolic disordersPASSINI MARCO A·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Dodge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →